Kazuki Sekitani
Director/Miembro de la Junta en EPS HOLDINGS, INC. .
Cargos activos de Kazuki Sekitani
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| EPS HOLDINGS, INC. | Director/Miembro de la Junta | 01/04/2011 | - |
| Oficial de Recursos Humanos | 21/12/2018 | - | |
| Public Communications Contact | 21/12/2018 | - | |
| Corporate Officer/Principal | 01/04/2011 | 21/12/2018 | |
| GNI GROUP LTD. | Director/Miembro de la Junta | 30/03/2023 | - |
| Independent Dir/Board Member | 30/03/2023 | - |
Historial de carrera de Kazuki Sekitani
Antiguos cargos conocidos de Kazuki Sekitani.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| KAKEN PHARMACEUTICAL CO., LTD. | Director/Miembro de la Junta | 01/06/2013 | - |
EPS Global Research, Inc.
 EPS Global Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of EPS Holdings, Inc., EPS Global Research, Inc. operates clinical trials. | Director/Miembro de la Junta | 01/06/2012 | - |
Formación de Kazuki Sekitani.
| University of Tokyo | Undergraduate Degree |
Estadísticas
Internacional
| Japón | 5 |
| Estados Unidos | 2 |
Operativa
| Director/Board Member | 4 |
| Human Resources Officer | 1 |
| Public Communications Contact | 1 |
Sectorial
| Health Technology | 4 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| KAKEN PHARMACEUTICAL CO., LTD. | Health Technology |
| GNI GROUP LTD. | Health Technology |
| Empresas privadas | 2 |
|---|---|
EPS Holdings, Inc.
 EPS Holdings, Inc. BiotechnologyHealth Technology EPS Holdings, Inc. engages in the drug development business. It operates through the following segments: Contract Research Organization (CRO), Site Management Organization (SMO), Contract Sales Organization (CSO), Global Research, Ekishin, and Others. The CRO segment offers clinical trials, data management, and statistical analysis. The SMO segment enters into contracts with medical institutions to conduct clinical trials. The CSO segment provides drug information and awareness for medical and pharmaceutical industries. The Global Research segment provides consignment services through its subsidiary for multilateral clinical trials in Asia-Pacific. The Ekishin segment focuses on medical equipment, pharmaceutical and investment related businesses through its Japan and China based subsidiaries. The Others segment provides various services related to management of clinical research from business processing outsource business related to medicine and medical care. The company was founded on May 30, 1991 and is headquartered in Tokyo, Japan. | Health Technology |
EPS Global Research, Inc.
EPS Global Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of EPS Holdings, Inc., EPS Global Research, Inc. operates clinical trials. | Commercial Services |
- Bolsa de valores
- Insiders
- Kazuki Sekitani
- Experiencia